Sergey Nazarov, co-founder of Chainlink, will speak at Sibos 2026, a major financial conference, across three sessions covering tokenized assets, intelligent money, and interoperable finance. The event, held from September 28 to October 1 in Miami Beach, focuses on digital finance for AI-driven economies. Chainlink's involvement highlights its growing role in traditional finance, including projects like Project Pangea aimed at improving cross-border FX settlements. Nazarov's sessions emphasize the future of programmable money and the importance of reliable data for AI in finance.
Chainlink co-founder Sergey Nazarov's participation at Sibos 2026 offers context for digital finance enthusiasts. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 22, 2026 02:02 WIB: out of 50 major cryptocurrencies priced on Pluang, 43 rose and 6 fell today. Notable movers include BAL (Balancer) at Rp16.297 with an 11.14% increase and a typical hold time of 85 days, SOL (Solana) at Rp2.096.662 up 8.15% with a 54% sell order activity, and EOS (EOS.IO) at Rp12.649 rising 8.13% with a typical hold time of 87 days.
Alkermes plc's drug ALKS7290 demonstrated significant improvement in ADHD symptoms in a Phase 1b trial, with patients showing a 14- to 19-point gain on a 54-point scale within two weeks. This outperforms typical placebo effects, which range from 6 to...
Fannie Mae completed its 28th sale of non-performing loans, selling 919 loans totaling $203.3 million in unpaid principal to Residential Credit Opportunities Trust IX-D. The loans have an average size of $221,222 and a weighted average interest rate ...
SanDisk shares fell 2% while the broader memory sector, including peers Micron and Western Digital, saw gains of 3% and 0.8% respectively. This divergence occurred without any company-specific news, suggesting profit-taking or position trimming after...
A class action lawsuit has been filed against Ardelyx, Inc. for allegedly misleading investors about the commercial performance and growth prospects of its key drugs, IBSRELA and XPHOZAH, between January 2025 and August 2026. The lawsuit claims Ardel...
Jim Cramer recommends investors to "own it, don't trade it" for Apple and NVIDIA, emphasizing long-term holding over short-term trading. Both companies are competing for the title of the world's most valuable publicly traded company, with NVIDIA lead...
